What are the practical considerations for monoclonal antibody infusion?
Measuring treatment response rates in multiple myeloma
Insights into the genomics of multiple myeloma - new drug targets and when to do a genomic analysis
Improving the outcomes of transplantation with bispecific antibodies
Which treatments are currently available for relapsed and refractory myeloma treatment?